As foundations increasingly collaborate with their fellow funders to leverage their impact as they address complex public problems, the logistical challenges to working together can be daunting.
Last week, the Monitor Institute and the Foundation Center released a report on their research into how new technologies can facilitate collaborations and reduce inefficiencies.
The research was included an extensive literature review on collaboration in philanthropy, detailed analyses of trends from a Foundation Center survey of the largest U.S. foundations, interviews with 37 leading philanthropy professionals and technology experts and a review of more than 170 online tools, according to a statement.
The report includes an introduction to emerging technologies and the changing context for philanthropic collaboration, an overview of collaborative needs and tools and recommendations for improving the collaborative technology landscape.
An interactive tool finder developed by GrantCraft, a joint service of the Foundation Center and the European Foundation Centre, presents seven distinct collaborative needs (including finding partners, designing strategies and assessing progress) and 17 types of tool functionalities (ranging from data gathering to project management) in an online matrix that facilitates intuitive exploration of available resources.
Steel Dynamics, Inc., together with its subsidiaries, engages in the manufacture and sale of steel products in the United States and internationally. The company operates in three segments: Steel Operations, Metals Recycling and Ferrous Resources Operations, and Steel Fabrication Operations. The Steel Operations segment provides a range of sheet steel products, including hot rolled, cold rolled, and coated steel products; structural steel beams, pilings, and rails; special bar quality and merchant bar quality rounds and round-cornered squares; billets and merchant steel products comprising angles, plain rounds, flats, and channels; and merchant beams and specialty structural steel sections. This segment offers its products for automotive, agriculture, energy, construction, commercial, transportation, and industrial machinery markets. The Metals Recycling and Ferrous Resources Operations segment purchases, processes, and resells ferrous products, such as heavy melting steel , busheling, bundled scrap, shredded scrap, steel turnings, and cast iron products; and processes nonferrous products consisting of aluminum, brass, copper, stainless steel, and other nonferrous metals for use in foundry, mill refining, and smelting applications. It also provides liquid pig iron and hot briquetted iron; and iron nugget products. The Steel Fabrication Operations segment fabricates steel building components, which include steel joists, trusses, girders, and decking products for the non-residential construction industry. The company was founded in 1993 and is headquartered in Fort Wayne, Indiana.
Advisors' Opinion: - [By Ben Levisohn]
The news has hit Nucor’s shares today. Its stock has dropped 1.4% to $51.30, even as U.S. Steel (X) has gained 0.3% to $27.20, AK Steel (AKS) has gained 1.2% to $6.10 and Steel Dynamics (STLD) has decline 0.1% to $18.95. Encana is little changes at $17.95.
- [By Ben Levisohn]
That dynamic means that companies that can benefit from construction strength and cut costs will outperform others. For that reason, Murphy keeps Nucor (NUE) and�Steel Dynamics (STLD) at Buy. He wasn’t so kind to Reliance Steel (RS), US Steel (X) and AK Steel (AKS), which were all cut, though for different reasons.
- [By Vladimir Zernov]
The first quarter was a tough one for steelmakers, as harsh winter weather raised costs and delayed shipments. AK Steel's (NYSE: AKS ) CEO James Wainscott even said, "thank goodness it's behind us" during the first quarter earnings call. Steel Dynamics (NASDAQ: STLD ) blamed weather conditions for reduced earnings, as cost rose due to higher electricity and natural gas costs. Nucor (NYSE: NUE ) and U.S. Steel (NYSE: X ) were hit by the weather as well.
Top Sliver Companies To Invest In 2015: Aflac Incorporated(AFL)
Aflac Incorporated, through its subsidiary, American Family Life Assurance Company of Columbus (Aflac), provides supplemental health and life insurance. The company offers various voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan. It also provides loss-of-income products, such as life and short-term disability plans; and products designed to protect individuals from depletion of assets, which comprise hospital indemnity, fixed-benefit dental, vision care, accident, cancer, critical illness/critical care, and hospital intensive care plans in the United States. The company sells its products through sales associates and brokers, affiliated corporate agencies, independent corporate agencies, and individual agencies. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.
Advisors' Opinion: - [By Chuck Carnevale]
Actually, there are several companies on these lists that qualified for either or both of my favorites lists. For example, Aflac (AFL) and or Emerson Electric (EMR) could easily be on both lists. My point is that I feel the reader should give the same consideration to each of these names as they would the two top 10 lists. To be clear, selecting the top 10 was difficult and therefore to a great extent subjective on my part. My method was to simply run a F.A.S.T. Graphs��on each Dividend Champion with above-average total return calculations. Then my lists were created by picking and choosing those companies that from my review looked best based on value, earnings and safety.
Top Sliver Companies To Invest In 2015: Hilltop Holdings Inc. (HTH)
Hilltop Holdings Inc., through its subsidiary, NLASCO, Inc., operates as a property and casualty insurance company in the United States. The company�s personal product line includes homeowners, dwelling fire, manufactured home, flood, and vacant insurance policies; and commercial product line consists of commercial, builders risk, builders risk renovation, sports liability, and inland marine insurance policies. It distributes its insurance products through a network of independent agents and managing general agents. The company was formerly known as Affordable Residential Communities Inc. and changed its name to Hilltop Holdings Inc. in July 2007. Hilltop Holdings Inc. was founded in 1948 and is headquartered in Dallas, Texas.
Advisors' Opinion: - [By Jake L'Ecuyer]
Meanwhile, top decliners in the sector included United Fire Group (NASDAQ: UFCS), down 4.9 percent, and Hilltop Holdings (NYSE: HTH), off 3.7 percent.
- [By Lauren Pollock]
Hilltop Holdings Inc.(HTH) offered to buy the rest of SWS Group Inc.(SWS) that it doesn’t already own, valuing the financial-services company at about $231 million. Hilltop, a regional banking and insurance company, offered $7 a share, a 16% premium over Thursday’s close. SWS surged 19% to $7.20 premarket,�topping the offer price.
- [By Roberto Pedone]
Hilltop (HTH) operates as a holding company for PlainsCapital Bank that provides business and consumer banking services in Texas. This stock closed up 8.7% at $17.96 in Monday's trading session.
Monday's Volume: 2.29 million
Three-Month Average Volume: 414,214
Volume % Change: 436%
From a technical perspective, HTH gapped up sharply higher here back above its 50-day moving average of $16.52 with strong upside volume. This move pushed shares of HTH into breakout and new 52-week-high territory, since the stock closed above some previous resistance at $17.63.
Traders should now look for long-biased trades in HTH as long as it's trending above Monday's low of $17.07 and then once it sustains a move or close above its new 52-week high at $18.23 with volume that this near or above 414,214 shares. If we get that move soon, then HTH will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that move are $20 to $23.
- [By Jake L'Ecuyer]
Meanwhile, top decliners in the sector included Tree.Com (NASDAQ: TREE), down 4.7 percent, and Hilltop Holdings (NYSE: HTH), off 6.7 percent.
Top Headline
Office Depot (NYSE: ODP) reported upbeat first-quarter results and announced its plans to close at least 400 stores in the United States. For the full year, Office Depot also lifted its adjusted operating income outlook to at least $160 million versus $140 million. Office Depot posted a quarterly net loss of $109 million, or $0.21 per share, versus a year-ago loss of $17 million, or $0.06 per share.
Top Sliver Companies To Invest In 2015: Pharmacyclics Inc (PCYC)
Pharmacyclics, Inc., incorporated on April 19, 1991, is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's clinical development and product candidates are small-molecule enzyme inhibitors designed to target biochemical pathways involved in human diseases. As of June 30, 2011, it had three drug candidates under clinical development and a number of preclinical lead molecules. This includes an inhibitor of Bruton�� tyrosine kinase (Btk) (PCI-32765) in Phase II studies in hematologic malignancies; a Btk inhibitor lead optimization program targeting autoimmune indications, an inhibitor of Factor VIIa (PCI-27483) in a Phase II clinical trial in pancreatic cancer, and a histone deacetylase (HDAC) inhibitor (PCI-24781) in Phase I and II clinical trials in solid tumors and hematological malignancies as of June 30, 2012.
As of June 30, 2012, the Company developed ibrutinib, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a variety of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse B-cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its current or planned Phase Ib/II and Phase III development program. had development programs for B-cell malignancies and autoimmune diseases. For malignant indications it has developed PCI-32765, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a range of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its Phase II development. It has developed an assay! to measure occupancy of Btk in PBMCs using a cell-permeable fluorescently-labeled derivative of PCI-32765.
Factor VII is an enzyme that becomes activated (FVIIa) by binding to the cell surface protein tissue factor (TF), a protein found in the body that helps to trigger the process of blood clotting in response to injury. TF is over expressed in many cancers including gastric, breast, colon, lung, prostate, ovarian and pancreatic cancers. In these tumors, the FVIIa/TF complex induces intracellular signaling pathways by activating protease activated receptor 2 (PAR-2), another cell-surface protein. This in turn increases the expression of interleukin-8 (IL-8), a protein produced by white blood cells and other immune cells in response to pathogenic stimulation, and vascular endothelial growth factor (VEGF), a signal protein produced by cells that stimulate the growth of blood vessels. Both proteins play an important role in tumor growth and metastases as well as angiogenesis (growth of new blood vessels). FVIIa/TF complex also initiates the coagulation (a process by which blood forms clots) processes implicated in the high incidence of thromboembolic (the process by which the blood clots within a blood vessel) complications seen in patients with TF-expressing cancers. Thromboembolic events are a cause of death in patients with cancer and anticoagulant treatment has been shown to improve survival in a variety of cancers (Klerk et al. JCO. 2005).
PCI-27483 Factor VIIa Inhibitor
The Company�� Factor VIIa inhibitor PCI-27483 is a first-in-human small molecule inhibitor that selectively targets FVIIa. As an inhibitor of FVIIa, PCI-27483 has two potential mechanisms of action: inhibition of intracellular signaling involved in tumor growth and metastases and inhibition of early coagulation processes associated with thromboembolism.
Factor VIIa PCI-27483 Clinical Development Update
A multicenter Phase I/II of PCI-27483 in patients with locally a! dvanced o! r metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). The objectives are to assess the safety of FVIIa Inhibitor PCI-27483 at pharmacologically active dose levels, to assess potential inhibition of tumor progression and to obtain initial information of the effects on the incidence of thromboembolic events. Due to a paradigm shift away from the use of gemcitabine alone for the treatment of pancreatic cancer, enrolling patients in this randomized study has been challenging. PCYC is evaluating other alternatives for development of this agent.
A multicenter Phase I/II of PCI-27483 in patients with locally advanced or metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). PCI-27483 is covered by United States patents and patent applications and counterpart patents and patent applications in fourteen ex-United States territories, including Europe, Canada, Mexico, Japan, China, India, South Korea, Australia and Brazil.
Advisors' Opinion: - [By Keith Speights]
Pharmacyclics (NASDAQ: PCYC ) and development partner Janssen, a division of Johnson & Johnson (NYSE: JNJ ) , announced on Wednesday that a New Drug Application, or NDA, has been submitted for ibrutinib. The NDA filed with the U.S. Food and Drug Administration requests marketing approval for the drug in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma and in the treatment of previously treated patients with mantle cell lymphoma.
- [By MONEYMORNING]
We saw this last year with such Private Briefing recommendations as The Boeing Co. (NYSE: BA) and Pharmacyclics Inc. (Nasdaq: PCYC), which rose more than 100% and 400%, respectively, following our recommendation.
- [By Sean Williams]
What's perhaps more remarkable is the fact that Pharmacyclics (NASDAQ: PCYC ) has three of those 23 approved breakthrough therapy designations for its lead experimental drug, ibrutinib. Ibrutinib, which is also licensed to Johnson & Johnson (NYSE: JNJ ) subsidiary Janssen Pharmaceuticals, was designated as a breakthrough therapy for patients with chronic lymphocytic leukemia, mantle cell lymphoma, and Waldenstrom's macroglobulinemia. The big potential indication here is CLL, which is the most common adulthood leukemia and occurs in 113,000 people in the U.S. By comparison, MCL diagnoses number about 5,000 each year.
Top Sliver Companies To Invest In 2015: Wintrust Financial Corporation(WTFC)
Wintrust Financial Corporation, through its subsidiaries, engages in community banking, specialty finance, and wealth management operations. Its Community Banking segment offers banking and financial services primarily to individuals, small to mid-sized businesses, local governmental units, and institutional customers. This segment?s products and services include deposit products, such as demand, negotiable order of withdrawal, money market, savings, and time deposit accounts; home equity, home mortgage, consumer, real estate, and commercial loans; safe deposit facilities; automated teller machines (ATMs); and Internet banking services. The company?s Specialty Finance segment offers financing for the payment of commercial insurance premiums to businesses and individuals; short-term accounts receivable financing; and out-sourced administrative services, including data processing of payrolls, billing, and cash management services to customers in the temporary staffing indu stry, as well as engages in the origination and purchase of residential mortgages for sale into the secondary market and provides the document preparation and other loan closing services to a network of mortgage brokers. This segment markets its products primarily through insurance agents and brokers. Its Wealth Management segment provides trust and investment services, asset management, and securities brokerage services, which are marketed primarily under the Wayne Hummer name. As of December 31, 2009, the company operated through 78 banking facilities, as well as owned 123 ATMs. Wintrust Financial Corporation was founded in 1992 and is based in Lake Forest, Illinois.
Advisors' Opinion: - [By Monica Gerson]
Wintrust Financial (NASDAQ: WTFC) is projected to post its Q4 earnings at $0.70 per share on revenue of $196.07 million.
International Business Machines (NYSE: IBM) is expected to post its Q4 earnings at $5.99 per share on revenue of $28.25 billion.
- [By Zacks]
Some better-ranked Midwest banks include First Interstate Bancsystem Inc. (NASDAQ: FIBK), Wintrust Financial Corporation (NASDAQ: WTFC) and PrivateBancorp, Inc. (NASDAQ: PVTB). All these stocks carry a Zacks Rank #1 (Strong Buy).
- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Citigroup Inc. (NYSE: C), Stanley Furniture Company, Inc. (NASDAQ: STLY), Wintrust Financial Corporation (NASDAQ: WTFC) Economic Releases Expected: Swiss PPI, eurozone industrial production Tuesday
Top Sliver Companies To Invest In 2015: Cbeyond Inc.(CBEY)
Cbeyond, Inc. provides managed information technology (IT) and communications services to small businesses in the United States. Its services include local and long-distance voice, broadband Internet, mobile services, broadband laptop access, voicemail, email, Web hosting, fax-to-email, data backup, file-sharing, virtual private networking, and cloud servers; and cloud applications, data center infrastructure as a service, cloud private branch exchange phone systems, metro Ethernet, multi-protocol label switching, information security, administration management, and professional services to migrate and manage customer environments. It sells its products and services through direct sales; value-added resellers, local area network consultants, and other IT and communications consultants; and managed services providers, systems integrators, and software vendors. The company was formerly known as Cbeyond Communications, Inc. and changed its name to Cbeyond, Inc. in July 2006. Cbeyond, Inc. was founded in 2000 and is headquartered in Atlanta, Georgia.
Advisors' Opinion: - [By Lisa Levin]
Cbeyond (NASDAQ: CBEY) shares gained 38.56% to touch a new 52-week high of $9.81 after the company agreed to be acquired by Birch Communications in all-cash transaction valued at $323 million.
- [By Lisa Levin]
Cbeyond (NASDAQ: CBEY) shares reached a new 52-week low of $6.07. Cbeyond's PEG ratio is -1.19.
Swisher Hygiene (NASDAQ: SWSH) shares touched a new 52-week low of $0.732. Swisher Hygiene appointed William Pierce as its new president and CEO.
Top Sliver Companies To Invest In 2015: Fujitsu Ltd (FJTSY)
Fujitsu Limited (Fujitsu), incorporated on June 20, 1935, is engaged in providing solutions in the field of information and communication technology. Along with multifaceted services provision, its business consists of the development, manufacture, sales and maintenance of the high-quality products and electronic devices that make these services possible. The Company operates in three segments: technology solutions, ubiquitous products solutions and device solutions. On June 4, 2009, Fujitsu introduced the docomo PRIME series F-09A mobile handset. On July 15, 2009, Fujitsu announces acquisition of shares in information technology (IT) subsidiary of AUTOBACS SEVEN. In October 2010, the Company and Toshiba Corporation announced that they have completed the merger of their mobile phone businesses. Effective August 15, 2013, Intel Corp acquired Fujitsu Semiconductor Wireless Products Inc, from Fujitsu Semiconductor Ltd, a wholly owned subsidiary of Fujitsu Ltd.
Technology solutions
Fujitsu provides solutions/system integration services focused on information system consulting and integration, and infrastructure services centered on outsourcing services (complete information system operation and management). Fujitsu offers system products, such as servers and storage systems, which form the backbone of information systems, along with network products, such as mobile phone base stations, optical transmission systems and other communications infrastructures. Its services include system integration (system construction), consulting, front-end technologies (automated teller machines (ATMs)), outsourcing services (datacenters, IT operation/management, software as a service (SaaS), application operation/management and business process outsourcing), network services (business networks, distribution of Internet/mobile content), system support services (maintenance and surveillance services for information systems and networks) and security solutions (installation of information systems an! d networks).
Ubiquitous products solutions
Fujitsu offers the personal computers (PCs), mobile phones and other products indispensable for realizing the emerging ubiquitous networked society. In PCs, along with more conventional desktop and notebook models, the Company develops netbooks and products with security features, providing a global lineup that allows customers to choose the product for their application. In mobile phones, it provide a variety of products that include high-performance models featuring specs and water resistance, separable mobile phone handset, and products created from collaborations with brands. Its products include PCs, mobile phones and optical transceiver modules.
Device solutions
LSI devices and electronic components comprise Fujitsu�� Device Solutions. Fujitsu Semiconductor, the Fujitsu operating company in semiconductors, provides LSI devices found in products, such as digital home appliances, automobiles, mobile phones and servers. The Company�� subsidiaries Shinko Electric Industries Co., Ltd. and Fujitsu Component Limited, along with FDK Corporation, provide semiconductor packages and other electronic components, as well as structural components, such as batteries, relays and connectors. Its products include LSI devices, electronic components (semiconductor packages), batteries and structural components (relays and connectors).
Advisors' Opinion: - [By MARKETWATCH]
LOS ANGELES (MarketWatch) -- A rising Japanese yen and weak results from Caterpillar Inc. (CAT) overnight sent Tokyo-listed shares lower in early Thursday trade, with the Nikkei Stock Average (JP:NIK) falling 0.4% to 14,363.59, while the Topix also lost 0.4%. With the U.S. dollar remaining below the 98-yen level amid concerns about the health of China's largest banks, some currency-sensitive shares extended their losses after driving the Nikkei Average down 2% in the previous session. Among them, trading house Mitsui & Co. (JP:8031) (MITSY) fell 1.3%, retail major J. Front Retailing Co. (JP:3086) lost 1.2%, auto maker Nissan Motor Co. (JP:7201) (NSANY) retreated 0.6%, and Fujitsu Ltd. (JP:6702) (FJTSY) traded 1% lower. The below-forecast quarterly results and outlook cut from U.S. construction-equipment maker Caterpillar sent its Japanese rivals tumbling, with Komatsu Ltd. (JP:6301) (KMTUF) dropping 3.5% and Hitachi Construction Macheriny Co. (JP:6305) (HTCMF) falling 3.1%. On the upside, Hitachi Ltd. (JP:6501) (HTHIF) soared 5.4% after raising its profit and revenue guidance for the fiscal first hal
